{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T21:53:27Z","timestamp":1793224407641,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Rheumatol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s00393-026-01797-2","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T09:25:35Z","timestamp":1773825935000},"page":"511-519","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Pathophysiologische Aspekte der prim\u00e4ren Sj\u00f6gren-Erkrankung","Pathophysiological aspects of primary Sj\u00f6gren\u2019s disease"],"prefix":"10.1007","volume":"85","author":[{"given":"Jacob","family":"Ritter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"D\u00f6rner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,18]]},"reference":[{"key":"1797_CR1","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41584-024-01135-3","volume":"20","author":"C Baldini","year":"2024","unstructured":"Baldini\u00a0C, Fulvio\u00a0G, La Rocca\u00a0G et\u00a0al (2024) Update on the pathophysiology and treatment of primary Sj\u00f6gren syndrome. Nat Rev Rheumatol 20:473\u2013491","journal-title":"Nat Rev Rheumatol"},{"key":"1797_CR2","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/s41584-023-01057-6","volume":"20","author":"M Beydon","year":"2024","unstructured":"Beydon\u00a0M, Mccoy\u00a0S, Nguyen\u00a0Y et\u00a0al (2024) Epidemiology of Sj\u00f6gren syndrome. Nat Rev Rheumatol 20:158\u2013169","journal-title":"Nat Rev Rheumatol"},{"key":"1797_CR3","doi-asserted-by":"publisher","first-page":"3767","DOI":"10.4049\/jimmunol.1201216","volume":"189","author":"M Bombardieri","year":"2012","unstructured":"Bombardieri\u00a0M, Barone\u00a0F, Lucchesi\u00a0D et\u00a0al (2012) Inducible tertiary lymphoid structures, autoimmunity, and exocrine dysfunction in a novel model of salivary gland inflammation in C57BL\/6 mice. J\u00a0Immunol 189:3767\u20133776","journal-title":"J Immunol"},{"key":"1797_CR4","doi-asserted-by":"crossref","unstructured":"Bruno D, Tolusso B, Lugli G et\u00a0al. (2024) B\u2011Cell Activation Biomarkers in Salivary Glands Are Related to Lymphomagenesis in Primary Sj\u00f6gren\u2019s Disease: A\u00a0Pilot Monocentric Exploratory Study. Int J Mol Sci 25","DOI":"10.3390\/ijms25063259"},{"key":"1797_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2025.102712","volume":"98","author":"L Chatzis","year":"2025","unstructured":"Chatzis\u00a0L, Palamidas\u00a0DA, D\u00f6rner\u00a0T (2025) Mapping the B\u2011cell axis in Sj\u00f6gren\u2019s disease: repertoire, microenvironment, and potential routes to precision treatment. Curr Opin Immunol 98:102712","journal-title":"Curr Opin Immunol"},{"key":"1797_CR6","first-page":"2020","volume":"43","author":"LG Chatzis","year":"2025","unstructured":"Chatzis\u00a0LG, Pontarini\u00a0E, Fulvio\u00a0G et\u00a0al (2025) Evolving mechanisms in the pathogenesis of Sj\u00f6gren\u2019s disease: one year in review 2025. Clin Exp Rheumatol 43:2020\u20132028","journal-title":"Clin Exp Rheumatol"},{"key":"1797_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1443455","volume":"15","author":"Y Dong","year":"2024","unstructured":"Dong\u00a0Y, Wang\u00a0T, Wu\u00a0H (2024) The role of cytokines from salivary gland epithelial cells in the immunopathology of Sj\u00f6gren\u2019s syndrome. Front Immunol 15:1443455","journal-title":"Front Immunol"},{"key":"1797_CR8","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1002\/art.42550","volume":"75","author":"PM Duret","year":"2023","unstructured":"Duret\u00a0PM, Schleiss\u00a0C, Kawka\u00a0L et\u00a0al (2023) Association Between Bruton\u2019s Tyrosine Kinase Gene Overexpression and Risk of Lymphoma in Primary Sj\u00f6gren\u2019s Syndrome. Arthritis Rheumatol 75:1798\u20131811","journal-title":"Arthritis Rheumatol"},{"key":"1797_CR9","doi-asserted-by":"publisher","first-page":"2770","DOI":"10.1073\/pnas.0510837103","volume":"103","author":"JE Gottenberg","year":"2006","unstructured":"Gottenberg\u00a0JE, Cagnard\u00a0N, Lucchesi\u00a0C et\u00a0al (2006) Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sj\u00f6gren\u2019s syndrome. Proc Natl Acad Sci U S A 103:2770\u20132775","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1797_CR10","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1002\/art.39204","volume":"67","author":"JC Hall","year":"2015","unstructured":"Hall\u00a0JC, Baer\u00a0AN, Shah\u00a0AA et\u00a0al (2015) Molecular Subsetting of Interferon Pathways in Sj\u00f6gren\u2019s Syndrome. Arthritis Rheumatol 67:2437\u20132446","journal-title":"Arthritis Rheumatol"},{"key":"1797_CR11","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1002\/art.10445","volume":"46","author":"A Hansen","year":"2002","unstructured":"Hansen\u00a0A, Odendahl\u00a0M, Reiter\u00a0K et\u00a0al (2002) Diminished peripheral blood memory B cells and accumulation of memory B cells in the salivary glands of patients with Sj\u00f6gren\u2019s syndrome. Arthritis & Rheumatism 46:2160\u20132171","journal-title":"Arthritis & Rheumatism"},{"key":"1797_CR12","unstructured":"Health NIO (2023) A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sj\u00f6gren\u2019s Syndrome (POETYK SjS-1). In: ClinicalTrials.gov; 2023. Identifier: NCT05946941. https:\/\/clinicaltrials.gov\/study\/NCT05946941"},{"key":"1797_CR13","unstructured":"Hudson E, Yang L, Chu EK et\u00a0al. (2024) Evidence that autoantibody production may be driven by acute Epstein-Barr virus infection in Sj\u00f6gren\u2019s disease. Ann Rheum Dis"},{"key":"1797_CR14","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1093\/rheumatology\/key330","volume":"60","author":"J Imgenberg-Kreuz","year":"2021","unstructured":"Imgenberg-Kreuz\u00a0J, Rasmussen\u00a0A, Sivils\u00a0K et\u00a0al (2021) Genetics and epigenetics in primary Sj\u00f6gren\u2019s syndrome. Rheumatology (Oxford) 60:2085\u20132098","journal-title":"Rheumatology (Oxford)"},{"key":"1797_CR15","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1136\/annrheumdis-2015-208659","volume":"75","author":"J Imgenberg-Kreuz","year":"2016","unstructured":"Imgenberg-Kreuz\u00a0J, Sandling\u00a0JK, Alml\u00f6f\u00a0JC et\u00a0al (2016) Genome-wide DNA methylation analysis in multiple tissues in primary Sj\u00f6gren\u2019s syndrome reveals regulatory effects at interferon-induced genes. Ann Rheum Dis 75:2029\u20132036","journal-title":"Ann Rheum Dis"},{"key":"1797_CR16","doi-asserted-by":"publisher","DOI":"10.1111\/sji.12662","volume":"87","author":"J Imgenberg-Kreuz","year":"2018","unstructured":"Imgenberg-Kreuz\u00a0J, Sandling\u00a0JK, Bj\u00f6rk\u00a0A et\u00a0al (2018) Transcription profiling of peripheral B cells in antibody-positive primary Sj\u00f6gren\u2019s syndrome reveals upregulated expression of CX3CR1 and a type I and type II interferon signature. Scand J Immunol 87:e12662","journal-title":"Scand J Immunol"},{"key":"1797_CR17","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1007\/s12026-024-09453-0","volume":"72","author":"J Kabeerdoss","year":"2024","unstructured":"Kabeerdoss\u00a0J, Devarajalu\u00a0P, Sandhya\u00a0P (2024) DNA methylation profiling of labial salivary gland tissues revealed hypomethylation of B\u2011cell-related genes in primary Sj\u00f6gren\u2019s syndrome. Immunol Res 72:450\u2013459","journal-title":"Immunol Res"},{"key":"1797_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1183195","volume":"14","author":"S Kamounah","year":"2023","unstructured":"Kamounah\u00a0S, Sembler-M\u00f8ller\u00a0ML, Nielsen\u00a0CH et\u00a0al (2023) Sj\u00f6gren\u2019s syndrome: novel insights from proteomics and miRNA expression analysis. Front Immunol 14:1183195","journal-title":"Front Immunol"},{"key":"1797_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30773-y","volume":"13","author":"B Khatri","year":"2022","unstructured":"Khatri\u00a0B, Tessneer\u00a0KL, Rasmussen\u00a0A et\u00a0al (2022) Genome-wide association study identifies Sj\u00f6gren\u2019s risk loci with functional implications in immune and glandular cells. Nat Commun 13:4287","journal-title":"Nat Commun"},{"key":"1797_CR20","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1038\/ng.2792","volume":"45","author":"CJ Lessard","year":"2013","unstructured":"Lessard\u00a0CJ, Li\u00a0H, Adrianto\u00a0I et\u00a0al (2013) Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sj\u00f6gren\u2019s syndrome. Nat Genet 45:1284\u20131292","journal-title":"Nat Genet"},{"key":"1797_CR21","doi-asserted-by":"crossref","unstructured":"Mariette X, Criswell LA (2018) Primary Sj\u00f6gren\u2019s Syndrome. New England Journal of Medicine","DOI":"10.1056\/NEJMcp1702514"},{"key":"1797_CR22","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1097\/BOR.0000000000000622","volume":"31","author":"M Ma\u015bli\u0144ska","year":"2019","unstructured":"Ma\u015bli\u0144ska\u00a0M (2019) The role of Epstein-Barr virus infection in primary Sj\u00f6gren\u2019s syndrome. Curr Opin Rheumatol 31:475\u2013483","journal-title":"Curr Opin Rheumatol"},{"key":"1797_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01135","volume":"9","author":"A Michalska","year":"2018","unstructured":"Michalska\u00a0A, Blaszczyk\u00a0K, Wesoly\u00a0J et\u00a0al (2018) A Positive Feedback Amplifier Circuit That Regulates Interferon (IFN)-Stimulated Gene Expression and Controls Type I and Type II IFN Responses. Front Immunol 9:1135","journal-title":"Front Immunol"},{"key":"1797_CR24","doi-asserted-by":"crossref","unstructured":"Mohammadnezhad L, Shekarkar Azgomi M, La Manna MP et\u00a0al. (2023) B\u2011Cell Receptor Signaling Is Thought to Be a\u00a0Bridge between Primary Sjogren Syndrome and Diffuse Large B\u2011Cell Lymphoma. Int J Mol Sci 24","DOI":"10.3390\/ijms24098385"},{"key":"1797_CR25","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nrrheum.2018.1","volume":"14","author":"G Nocturne","year":"2018","unstructured":"Nocturne\u00a0G, Mariette\u00a0X (2018) B cells in the pathogenesis of primary Sj\u00f6gren syndrome. Nature Reviews Rheumatology 14:133\u2013145","journal-title":"Nature Reviews Rheumatology"},{"key":"1797_CR26","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/nri1604","volume":"5","author":"LC Platanias","year":"2005","unstructured":"Platanias\u00a0LC (2005) Mechanisms of type-I- and type-II-interferon-mediated signalling. Nature Reviews Immunology 5:375\u2013386","journal-title":"Nature Reviews Immunology"},{"key":"1797_CR27","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1136\/annrheumdis-2020-217646","volume":"79","author":"E Pontarini","year":"2020","unstructured":"Pontarini\u00a0E, Murray-Brown\u00a0WJ, Croia\u00a0C et\u00a0al (2020) Unique expansion of IL-21+ Tfh and Tph cells under control of ICOS identifies Sj\u00f6gren\u2019s syndrome with ectopic germinal centres and MALT lymphoma. Ann Rheum Dis 79:1588\u20131599","journal-title":"Ann Rheum Dis"},{"key":"1797_CR28","unstructured":"Pranzatelli TJF, Perez P, Ku A et\u00a0al. (2025) GZMK(+)CD8(+) T\u00a0cells target a\u00a0specific acinar cell type in Sj\u00f6gren\u2019s disease. Ann Rheum Dis"},{"key":"1797_CR29","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/s41584-025-01268-z","volume":"21","author":"M Ramos-Casals","year":"2025","unstructured":"Ramos-Casals\u00a0M, Baer\u00a0AN, Brito-Zer\u00f3n\u00a0MDP et\u00a0al (2025) 2023 International Rome consensus for the nomenclature of Sj\u00f6gren disease. Nat Rev Rheumatol 21:426\u2013437","journal-title":"Nat Rev Rheumatol"},{"key":"1797_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2022.105406","volume":"89","author":"J Ritter","year":"2022","unstructured":"Ritter\u00a0J, Chen\u00a0Y, Stefanski\u00a0AL et\u00a0al (2022) Current and future treatment in primary Sj\u00f6gren\u2019s syndrome - A still challenging development. Joint Bone Spine 89:105406","journal-title":"Joint Bone Spine"},{"key":"1797_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2024.103243","volume":"147","author":"J Ritter","year":"2024","unstructured":"Ritter\u00a0J, Szelinski\u00a0F, Aue\u00a0A et\u00a0al (2024) Elevated unphosphorylated STAT1 and IRF9 in T and B cells of primary sj\u00f6gren\u2019s syndrome: Novel biomarkers for disease activity and subsets. J\u00a0Autoimmun 147:103243","journal-title":"J Autoimmun"},{"key":"1797_CR32","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1136\/annrheumdis-2019-216588","volume":"79","author":"R E","year":"2020","unstructured":"E\u00a0R, J\u00a0P, N\u00a0T et\u00a0al (2020) Salivary gland epithelial cells from patients with Sj\u00f6gren\u2019s syndrome induce B\u2011lymphocyte survival and activation. Ann Rheum Dis 79:1468\u20131477","journal-title":"Ann Rheum Dis"},{"key":"1797_CR33","doi-asserted-by":"publisher","first-page":"3187","DOI":"10.1002\/art.11311","volume":"48","author":"S Salomonsson","year":"2003","unstructured":"Salomonsson\u00a0S, Jonsson\u00a0MV, Skarstein\u00a0K et\u00a0al (2003) Cellular basis of ectopic germinal center formation and autoantibody production in the target organ of patients with Sj\u00f6gren\u2019s syndrome. Arthritis Rheum 48:3187\u20133201","journal-title":"Arthritis Rheum"},{"key":"1797_CR34","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/s41584-021-00605-2","volume":"17","author":"GM Verstappen","year":"2021","unstructured":"Verstappen\u00a0GM, Pringle\u00a0S, Bootsma\u00a0H et\u00a0al (2021) Epithelial-immune cell interplay in primary Sj\u00f6gren syndrome salivary gland pathogenesis. Nat Rev Rheumatol 17:333\u2013348","journal-title":"Nat Rev Rheumatol"},{"key":"1797_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03750-7","volume":"9","author":"S Wang","year":"2018","unstructured":"Wang\u00a0S, Wang\u00a0J, Kumar\u00a0V et\u00a0al (2018) IL-21 drives expansion and plasma cell differentiation of autoreactive CD11c(hi)T-bet(+) B cells in SLE. Nat Commun 9:1758","journal-title":"Nat Commun"},{"key":"1797_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1289492","volume":"15","author":"Y Wang","year":"2024","unstructured":"Wang\u00a0Y, Riaz\u00a0F, Wang\u00a0W et\u00a0al (2024) Functional significance of DNA methylation: epigenetic insights into Sj\u00f6gren\u2019s syndrome. Front Immunol 15:1289492","journal-title":"Front Immunol"},{"key":"1797_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02136","volume":"10","author":"SY Wei\u00dfenberg","year":"2019","unstructured":"Wei\u00dfenberg\u00a0SY, Szelinski\u00a0F, Schrezenmeier\u00a0E et\u00a0al (2019) Identification and Characterization of Post-activated B Cells in Systemic Autoimmune Diseases. Front Immunol 10:2136","journal-title":"Front Immunol"},{"key":"1797_CR38","first-page":"1511","volume":"149","author":"S Wen","year":"1996","unstructured":"Wen\u00a0S, Shimizu\u00a0N, Yoshiyama\u00a0H et\u00a0al (1996) Association of Epstein-Barr virus (EBV) with Sj\u00f6gren\u2019s syndrome: differential EBV expression between epithelial cells and lymphocytes in salivary glands. Am J Pathol 149:1511\u20131517","journal-title":"Am J Pathol"},{"key":"1797_CR39","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1016\/j.jds.2023.12.024","volume":"19","author":"Y Xing","year":"2024","unstructured":"Xing\u00a0Y, Li\u00a0B, Wei\u00a0P et\u00a0al (2024) Profiles of peripheral B cell subsets in a cohort of primary Sj\u00f6gren\u2019s syndrome patients and their potential clinical significance. J\u00a0Dent Sci 19:1554\u20131563","journal-title":"J Dent Sci"},{"key":"1797_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-020-02249-1","volume":"22","author":"K Yoshimoto","year":"2020","unstructured":"Yoshimoto\u00a0K, Suzuki\u00a0K, Takei\u00a0E et\u00a0al (2020) Elevated expression of BAFF receptor, BR3, on monocytes correlates with B cell activation and clinical features of patients with primary Sj\u00f6gren\u2019s syndrome. Arthritis Res Ther 22:157","journal-title":"Arthritis Res Ther"},{"key":"1797_CR41","unstructured":"Ritter, J. (2026) https:\/\/BioRender.com\/wnbk5se."}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-026-01797-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00393-026-01797-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-026-01797-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T08:53:56Z","timestamp":1788944036000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00393-026-01797-2"}},"subtitle":["Von epithelialer Aktivierung zur systemischen Autoimmunit\u00e4t","From epithelial activation to systemic autoimmunity"],"short-title":[],"issued":{"date-parts":[[2026,3,18]]},"references-count":41,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["1797"],"URL":"https:\/\/doi.org\/10.1007\/s00393-026-01797-2","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,18]]},"assertion":[{"value":"7 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"T.\u00a0D\u00f6rner: DFG-F\u00f6rderung Do491\/14\u20111; 13\u20113; KFO \u201eBecause Y\u201c TP 7; BMBF F\u00f6rderung CURE-ME. Wissenschaftliche Beratung und klinische Studien: Abelzeta, Argenx, Bayer, BMS, J&J, Novartis, Roche\/GNE. J.\u00a0Ritter gibt an, dass kein Interessenkonflikt besteht.","order":1,"name":"Ethics","label":"Interessenkonflikt","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}}]}}